[
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Therefore, mechanisms underlying resistance and strategies to reverse resistance via targeted EGFR therapy must be further explored.Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The activation of endothelial nitric oxide synthase (eNOS)12 increases vascular permeability13 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Phosphorylated PDGFR regulates cell proliferation and migration via PI3K-AKT19 and other signaling pathways, thereby participating in tumor angiogenesis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EGFR is activated by phosphorylation and is involved in regulation of tumor angiogenesis via its downstream signaling pathways (MAPK, PI3K/AKT/PKB, STAT, and PLCγ/PKC)21 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Other factors\nBeyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Beyond the VEGF/VEGFR, EGF/EGFR, and PDGF/PDGFR axes, many other growth factors play indispensable roles in angiogenesis, such as fibroblast growth factor (FGF)/FGFR4, hepatocyte growth factor (HGF)/c-Met, insulin-like growth factor (IGF)/IGFR, and transforming growth factor (TGF-β) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Muoio et al. have reported that elevated IGF expression in patients with obesity and diabetes promotes breast cancer angiogenesis via the S7A1/RAGE downstream signaling pathway26 (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of HIF-2 has been shown to eliminate the increase in RAB1B-AS231 expression, thereby decreasing angiogenesis in breast cancer30 (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Tumor epithelial cell transition to endothelial cell phenotypes subsequently promotes the proliferation of tumor vascular endothelial cells and angiogenesis32 (Figure 2A) Numerous EET-associated signaling pathways are directly or indirectly regulated by hypoxia.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Under hypoxia, binding of HIF to HRE promotes the transcription of Twist, Snail, and ZEB233–35 (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF participates in the expression of glutathione S-transferase omega 1 (GSTO1), thereby promoting endoplasmic reticulum release of Ca2+; inducing the recruitment of CSC through the PYK2 → SRC → STAT3 signal transduction induced by cisplatin; and contributing to the occurrence of drug resistance in breast cancer49 (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, whether HIF-1α directly promotes the expression of breast cancer stem cell phenotypes has not been validated (Figure 3B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, this kinase cascade enhances the transcriptional activity of HIF-1α by binding the TAD sequence of HIF-1α through the transcriptional co-activators p300/CBP (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The loss of PTEN promotes activation of the PI3K/AKT pathway, and its downstream mTOR protein activates eIF-4E and consequently promotes the translation of HIF-1α protein50,51 (Figure 3D).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel D",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "HIF-1α forms a heterodimer with HIF-1β in the cytoplasm, translocates into the nucleus, and binds specific HREs on DNA, where it acts as a transcription factor for the downstream target gene VEGF (Figure 3E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel E",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "High VEGF expression during angiogenesis in breast cancer decreases CD8 T-cell levels via the HMG-bOX (TOX) pathway, thereby increasing tumor-cell tolerance to immunotherapy70 (Figure 3F).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel F",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "FasL promotes the tumor-specific exclusion of cytotoxic T-cells, facilitates the formation of an immunosuppressive TME, and leads to the development of drug resistance71 (Figure 3G).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel G",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, vascular endothelial cells in the breast cancer microenvironment release several miRNAs (miR-142-5p, miR-183-5p, and miR-222-3p) that are transported through extracellular vesicles, and subsequently regulate macrophage remodeling and promote macrophage polarization toward the M2 phenotype73 (Figure 3H).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel H",
        "figure_key": "figure_3"
      }
    ]
  }
]